MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Continuous levodopa- carbidopa gel recovers motor cortex plasticity in advanced Parkinson’s disease

K. Kolmancic, N. Prezelj, N. Kriznar Zupancic, M. Trost, D. Flisar, M. Gregoric Kramberger, R. Rajnar, Z. Pirtosek, M. Kojovic (Ljubljana, Slovenia)

Meeting: 2019 International Congress

Abstract Number: 1223

Keywords: Levodopa(L-dopa), Parkinsonism, Transcranial magnetic stimulation(TMS)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Neurophysiology

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: The objective of this study was to investigate if continuous infusion of levodopa- carbidopa gel (LCIG) improves motor complications of Parkinson’s disease (PD) and reverse its associated maladaptive changes of plasticity.

Background: In PD chronic pulsatile treatment with oral levodopa causes maladaptive changes in the cortico- basal ganglia- talamo- cortical circuit, which underlie motor complications such as motor fluctuations and levodopa- induced dyskinesias. Using transcranial magnetic stimulation (TMS), these changes may be detected at the level of sensorimotor cortex and consist of an absent response to plasticity protocols even when patients are tested under dopaminergic medications.

Method: 17 patients with advanced PD with average age 72.5 and disease duration 14 years have been enrolled so far. All of them underwent TMS experiments two days before and ten amongst them six months after the introduction of LCIG. We measured motor thresholds, input/output curve, intracortical inhibition and response to intermittent theta burst stimulation (iTBS) plasticity protocol over the hemisphere corresponding to the more affected side.  Patients were in the clinically defined »on« state. Clinical assessment was performed using MDS- UPDRS part III and IV scales.

Results: There was no significant change in the UPDRS part III in the »on« state, however there was a clear trend for improvement of motor complications with LCIG (MDS-UPDRS part IV; p=0.12). While the response to iTBS was absent on oral dopaminergic medications, LCIG significantly recovered motor cortex plasticity (p=0.020) (Figure 1). There were no changes in other TMS parameters.

Conclusion: LCIG is able to restore impaired response to iTBS, in parallel with an improvement in motor complications. Continuous dopaminergic treatment may reverse maladaptive changes related to chronic pulsatile dopaminergic treatment.

Figure1

To cite this abstract in AMA style:

K. Kolmancic, N. Prezelj, N. Kriznar Zupancic, M. Trost, D. Flisar, M. Gregoric Kramberger, R. Rajnar, Z. Pirtosek, M. Kojovic. Continuous levodopa- carbidopa gel recovers motor cortex plasticity in advanced Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/continuous-levodopa-carbidopa-gel-recovers-motor-cortex-plasticity-in-advanced-parkinsons-disease/. Accessed July 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/continuous-levodopa-carbidopa-gel-recovers-motor-cortex-plasticity-in-advanced-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley